Tobias Dittrich

AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis

Tobias Dittrich, Tilmann Bochtler, Christoph Kimmich et al. · Blood · 2017 · 133 citations · Full text

Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria

Christoph Kimmich, Tobias Terzer, Axel Benner et al. · Blood · 2020 · 85 citations · Full text

Localized immunoglobulin light chain amyloidosis: Novel insights including prognostic factors for local progression

Marco Basset, Kamal Hummedah, Christoph Kimmich et al. · American Journal of Hematology · 2020 · 49 citations · Full text

Local Progression, Prognostic Factors, Inflammatory Lung Disease +23

CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma—Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance

Anja Seckinger, Jens Hillengaß, Martina Emde et al. · Frontiers in Immunology · 2018 · 44 citations · Full text

Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia

Tobias Dittrich, Axel Benner, Christoph Kimmich et al. · Haematologica · 2019 · 43 citations · Full text